Skip Navigation
 

In Ok Surh, Ph.D.

General Toxicology Group

In Ok Surh, Ph.D.
In Ok Surh, Ph.D.
Research Fellow
Tel (919) 541-3862
surhi@niehs.nih.gov
P.O. Box 12233
Mail Drop K2-12
Research Triangle Park, North Carolina 27709
Delivery Instructions

Inok Surh, Ph.D. is a research fellow in the Toxicology Branch of the National Toxicology Program (NTP). She designs toxicological studies, develops study protocols, interprets results and publishes findings for chemicals selected for toxicological evaluation. Currently, she leads several projects that involve herbal medicines, chemical intermediates, and environmental contaminants. These studies include in vivo and in vitro evaluation for carcinogenicity, reproductive toxicity, developmental toxicity, genetic toxicity and toxicokinetics. She has a particular interest in mechanisms of carcinogenic activity of chemicals.

 

Surh received a B.S. in pharmacy and a M.S in hygienic chemistry from Duksung Women’s University, Korea. She is a licensed pharmacist in Korea and holds a Ph.D. in pharmacy from the University of Texas at Austin, Texas.

 

Selected Publications

National Toxicology Program

National Toxicology Program (NTP) Data and Reports Website 

  1. Surh, I., Behl, M., Elmore, S. and Chhabra, R. S. (2011) Comparative dermal toxicity of dicyclohexylcarbodiimide and diisopropylcarbodiimide in rodents. Cutan. Ocul. Toxicol. (in press) [Abstract (http://www.ncbi.nlm.nih.gov/pubmed/22060820) ]
  2. Surh, I. and Fischer, S. M. (2011) The EP1 receptor for prostaglandin E2 promotes the development and progression of malignant murine skin tumors. Mol. Carcinog. (in press) [Abstract (http://www.ncbi.nlm.nih.gov/pubmed/21739481) ]
  3. Rundhaug, J., Simper, M. S., Surh, I., and Fischer, S. M. (2011) The role of the EP receptors for prostaglandin E2 in skin and skin cancer. Cancer Metastasis Rev. 30(3-4):465-80 [Abstract (http://www.ncbi.nlm.nih.gov/pubmed/22012553) ]
  4. Surh, I., Rundhaug, J., Pavone, A., Mikulec, C., Abel, E., and Fischer, S.M. (2011) Upregulation of the EP1 receptor for prostaglandin E2 promotes skin tumor progression. Mol. Carcinog. 50(6):458-468 [Abstract (http://www.ncbi.nlm.nih.gov/pubmed/21268127) ]

Back to Top